Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Dewhurst Martin William — TETRAGENEX PHARMACEUTICALS, INC. insider: 2 transactions · InsiderLens

Home / Insiders / Dewhurst Martin William

Dewhurst Martin William

Director at TETRAGENEX PHARMACEUTICALS, INC. · on record since Jun 8, 2026

Insider trading activity of Dewhurst Martin William

Transactions on record: 2; since Feb 4, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 8, 2026

Figures computed from official regulatory filings — methodology.

Companies where Dewhurst Martin William has traded

TETRAGENEX PHARMACEUTICALS, INC.2 tx · Jun 8, 2026

Track record of Dewhurst Martin William

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Dewhurst Martin William

Co-insiders of Dewhurst Martin William

Abel DavidTETRAGENEX PHARMACEUTICALS, INC.
Akerman Alf E FTETRAGENEX PHARMACEUTICALS, INC.
BEB Holdings, LLCTETRAGENEX PHARMACEUTICALS, INC.
Bergman Bruce JTETRAGENEX PHARMACEUTICALS, INC.
Budetti Robert PeterTETRAGENEX PHARMACEUTICALS, INC.
Burnam Bradley EvanTETRAGENEX PHARMACEUTICALS, INC.
Cartwright KennethTETRAGENEX PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Chaudhary ZuraizTETRAGENEX PHARMACEUTICALS, INC.

Chesed AbrahamTETRAGENEX PHARMACEUTICALS, INC.

COHEN AARONTETRAGENEX PHARMACEUTICALS, INC.

COMER WILLIAM TTETRAGENEX PHARMACEUTICALS, INC.

Gengos AndrewTETRAGENEX PHARMACEUTICALS, INC.

Ghodadra Neilesh ShaileshTETRAGENEX PHARMACEUTICALS, INC.

GOLDEN ARTHUR FTETRAGENEX PHARMACEUTICALS, INC.

Hamlin John W JRTETRAGENEX PHARMACEUTICALS, INC.

Kester Kent EdwardTETRAGENEX PHARMACEUTICALS, INC.

Martucci NeilTETRAGENEX PHARMACEUTICALS, INC.

SCHACKER MARTIN FTETRAGENEX PHARMACEUTICALS, INC.

SHENK WILLIAM ATETRAGENEX PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
TETRAGENEX PHARMACEUTICALS, INC.	Jun 8, 2026	AwardD	71,666	0.00 USD	$0	SEC
TETRAGENEX PHARMACEUTICALS, INC.	Feb 4, 2026	Award	21,882	0.00 USD	$0	SEC